Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Pulmonary arterial hypertension’s prevalence and rate of progression in patients with connective ...

Stephanie Daniels couldn't bend down to put on her socks. She noticed the first symptoms of scleroderma about 2 1/2 years ago while attending St. Edward's University in Austin. The disease's name ...

SAN FRANCISCO--(BUSINESS WIRE)--The Scleroderma Research Foundation (SRF), the nation’s largest non-profit funder of scleroderma research, today announced that Sanofi will contribute the first ...

Please provide your email address to receive an email when new articles are posted on . The last 3 years of drug development in scleroderma have come to represent everything that ails the current ...

Scleroderma, or systemic sclerosis refers to a disorder in which the skin and connective tissues of the body start to thicken and harden because of the overproduction of a protein called collagen.

Medical learners in the 21st century spend less time with patients during training than their counterparts did in the 20th century, which decreases the knowledge and practice of bedside clinical ...

Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Design by Evelyn Mousigian. Dr. John Varga, rheumatology, internal medicine and dermatology ...

They’re stressful. They’re tough. They’re the OSCEs: Exams that train you — the medical student — to be the best doctor you can be. OSCE stands for objective structured clinical examination, and it’s ...

Much of the research on scleroderma, a connective tissue disease that causes scarring, or fibrosis, has focused on the increased number of proteins promoting fibrosis in these patients. A Medical ...